Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Author Correction: Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors.

Smolarczyk R, Cichoń T, Pilny E, Jarosz-Biej M, Poczkaj A, Kułach N, Szala S.

Sci Rep. 2020 Mar 25;10(1):5698. doi: 10.1038/s41598-020-62440-x.

2.

PHLDA1 Does Not Contribute Directly to Heat Shock-Induced Apoptosis of Spermatocytes.

Janus P, Mrowiec K, Vydra N, Widłak P, Toma-Jonik A, Korfanty J, Smolarczyk R, Widłak W.

Int J Mol Sci. 2019 Dec 30;21(1). pii: E267. doi: 10.3390/ijms21010267.

3.

Monitoring of diffusion properties and transverse relaxation time of mouse ischaemic muscle after administration of human mesenchymal stromal cells derived from adipose tissue.

Skorupa A, Ciszek M, Pilny E, Smolarczyk R, Jarosz-Biej M, Boguszewicz Ł, Krakowczyk Ł, Szala S, Sokół M, Cichoń T.

Cell Prolif. 2019 Nov;52(6):e12672. doi: 10.1111/cpr.12672. Epub 2019 Aug 23.

4.

The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells.

Czapla J, Matuszczak S, Kulik K, Wiśniewska E, Pilny E, Jarosz-Biej M, Smolarczyk R, Sirek T, Zembala MO, Zembala M, Szala S, Cichoń T.

Stem Cell Res Ther. 2019 Aug 5;10(1):235. doi: 10.1186/s13287-019-1331-9.

5.

Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy.

Jarosz-Biej M, Smolarczyk R, Cichoń T, Kułach N.

Int J Mol Sci. 2019 Jun 29;20(13). pii: E3212. doi: 10.3390/ijms20133212. Review.

6.

Human ADSC xenograft through IL-6 secretion activates M2 macrophages responsible for the repair of damaged muscle tissue.

Pilny E, Smolarczyk R, Jarosz-Biej M, Hadyk A, Skorupa A, Ciszek M, Krakowczyk Ł, Kułach N, Gillner D, Sokół M, Szala S, Cichoń T.

Stem Cell Res Ther. 2019 Mar 13;10(1):93. doi: 10.1186/s13287-019-1188-y.

7.

Bioresorbable filomicelles for targeted delivery of betulin derivative - In vitro study.

Jelonek K, Kasperczyk J, Li S, Nguyen THN, Orchel A, Chodurek E, Paduszyński P, Jaworska-Kik M, Chrobak E, Bębenek E, Boryczka S, Jarosz-Biej M, Smolarczyk R, Foryś A.

Int J Pharm. 2019 Feb 25;557:43-52. doi: 10.1016/j.ijpharm.2018.12.033. Epub 2018 Dec 18.

PMID:
30576789
8.

Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors.

Smolarczyk R, Cichoń T, Pilny E, Jarosz-Biej M, Poczkaj A, Kułach N, Szala S.

Sci Rep. 2018 May 9;8(1):7355. doi: 10.1038/s41598-018-25688-y. Erratum in: Sci Rep. 2020 Mar 25;10(1):5698.

9.

M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.

Jarosz-Biej M, Kamińska N, Matuszczak S, Cichoń T, Pamuła-Piłat J, Czapla J, Smolarczyk R, Skwarzyńska D, Kulik K, Szala S.

PLoS One. 2018 Jan 10;13(1):e0191012. doi: 10.1371/journal.pone.0191012. eCollection 2018.

10.

Antitumor activity of opiorphin, sialorphin and their conjugates with a peptide klaklakklaklak.

Kamysz E, Smolarczyk R, Cichoń T, Jarosz-Biej M, Sikorska E, Sobocińska M, Jaśkiewicz M, Kamysz W.

J Pept Sci. 2016 Nov;22(11-12):723-730. doi: 10.1002/psc.2936. Epub 2016 Nov 9.

PMID:
27862720
11.

Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice.

Czapla J, Matuszczak S, Wiśniewska E, Jarosz-Biej M, Smolarczyk R, Cichoń T, Głowala-Kosińska M, Śliwka J, Garbacz M, Szczypior M, Jaźwiec T, Langrzyk A, Zembala M, Szala S.

PLoS One. 2016 Jul 14;11(7):e0158745. doi: 10.1371/journal.pone.0158745. eCollection 2016.

12.

Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice.

Jarosz-Biej M, Smolarczyk R, Cichoń T, Kułach N, Czapla J, Matuszczak S, Szala S.

Arch Immunol Ther Exp (Warsz). 2015 Dec;63(6):451-64. doi: 10.1007/s00005-015-0337-y. Epub 2015 Mar 24.

13.

Active heat shock transcription factor 1 supports migration of the melanoma cells via vinculin down-regulation.

Toma-Jonik A, Widlak W, Korfanty J, Cichon T, Smolarczyk R, Gogler-Piglowska A, Widlak P, Vydra N.

Cell Signal. 2015 Feb;27(2):394-401. doi: 10.1016/j.cellsig.2014.11.029. Epub 2014 Nov 27.

14.

Characteristic of c-Kit+ progenitor cells in explanted human hearts.

Matuszczak S, Czapla J, Jarosz-Biej M, Wiśniewska E, Cichoń T, Smolarczyk R, Kobusińska M, Gajda K, Wilczek P, Sliwka J, Zembala M, Zembala M, Szala S.

Clin Res Cardiol. 2014 Sep;103(9):711-8. doi: 10.1007/s00392-014-0705-3. Epub 2014 Apr 11.

15.

D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.

Cichoń T, Smolarczyk R, Matuszczak S, Barczyk M, Jarosz M, Szala S.

Arch Immunol Ther Exp (Warsz). 2014 Aug;62(4):341-51. doi: 10.1007/s00005-014-0268-z. Epub 2014 Feb 2.

16.

Synthesis and analysis of activity of a potential anti-melanoma prodrug with a hydrazine linker.

Frąckowiak-Wojtasek B, Gąsowska-Bajger B, Mazurek M, Raniszewska A, Logghe M, Smolarczyk R, Cichoń T, Szala S, Wojtasek H.

Eur J Med Chem. 2014 Jan;71:98-104. doi: 10.1016/j.ejmech.2013.10.080. Epub 2013 Nov 9.

PMID:
24287558
17.

Antitumor effects of recombinant antivascular protein ABRaA-VEGF121 combined with IL-12 gene therapy.

Ciomber A, Smagur A, Mitrus I, Cichoń T, Smolarczyk R, Sochanik A, Szala S, Jarosz M.

Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):161-8. doi: 10.1007/s00005-013-0259-5. Epub 2013 Nov 13.

18.

[HMGB1--its role in tumor progression and anticancer therapy].

Smolarczyk R, Cichoń T, Jarosz M, Szala S.

Postepy Hig Med Dosw (Online). 2012 Nov 22;66:913-20. doi: 10.5604/17322693.1021108. Review. Polish.

19.

["Vicious circles" of glioblastoma tumors: vascularization and invasiveness].

Szala S, Jarosz M, Smolarczyk R, Cichoń T.

Postepy Hig Med Dosw (Online). 2012 Nov 16;66:888-900. doi: 10.5604/17322693.1019657. Review. Polish.

20.

Vasostatin increases oxygenation of B16-F10 melanoma tumors and raises therapeutic efficacy of cyclophosphamide.

Cichoń T, Jarosz M, Smolarczyk R, Ogórek B, Matuszczak S, Wagner M, Mitrus I, Sochanik A, Jazowiecka-Rakus J, Szala S.

Acta Biochim Pol. 2012;59(3):377-81. Epub 2012 Sep 3.

Supplemental Content

Loading ...
Support Center